CAMBRIDGE, Mass., Dec. Thirty (HSMN NewsFeed) — Biopure Corporation (Nasdaq: BPUR ) announced today that the Food and Drug Administration has advised the U.S. Naval Medical Research Center ("NMRC") by letter that it may not initiate a clinical tri…
Biopharmaceuticals
Biopure, Hemopure

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “U.S. Navy Requested Operations Trial on FDA Hold”
Leave a Comment